Experience

BioGenCell LTD

• Israel
• Biotechnology
• 1 - 100 Employee

• Founder, CEO

  • Dec 2008 - Present

  Israel BioGenCell is a company focused on the development of groundbreaking cellular therapies for people in need. Derived from the patient’s own adult stem cells, these easy-to-use and cost-effective therapies can regenerate damaged tissues and will eventually be used to treat a wide range of degenerative diseases, including diabetes, heart failure, stroke, blindness, cancer, and immunological diseases.



Braude Academic College

• Israel
• Higher Education
• 200 - 300 Employee

• Lecturer

  • 2011 - Jun 2019

  Lecturer on cell-based product development in the Masters in Biotechnology program. Lectures include biotechnology issues related to research, product development, clinical trials and regulations, as well as project/company management issues related to marketing research from development to marketing, competition and risk management.



Laniado Hospital

• Israel
• Hospitals and Health Care
• 100 - 200 Employee

• Head of Hematology BGC Stem Cell Research Center

  • Dec 2008 - Jun 2016

  Divrey Haim 16, Netanya, Israel Managing basic and diagnostic laboratory research in support of the academic efforts at the Laniado Hospital.



Theravitae

• Biotechnology Research
• 1 - 100 Employee

• CTO

  • Jan 2004 - Dec 2007

  Israel Established the R&D and manufacturing departments and managed all subsequent innovative research, development and production of GMP-compliant adult stem cell-based products used for preclinical and clinical studies, as well as for the routine treatment of patients. Dr. Porat’s team used the technological achievements they gained during the development of this technology to generate a solid IP portfolio including five patent applications, three scientific articles, numerous poster and oral… Show more Established the R&D and manufacturing departments and managed all subsequent innovative research, development and production of GMP-compliant adult stem cell-based products used for preclinical and clinical studies, as well as for the routine treatment of patients. Dr. Porat’s team used the technological achievements they gained during the development of this technology to generate a solid IP portfolio including five patent applications, three scientific articles, numerous poster and oral presentations, as well as a significant development pipeline. These accomplishments were honored by the World Economic Forum based in Geneva, which named TheraVitae as a Technology Pioneer for 2006. Show less



Teva Pharmaceuticals

• Israel
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Manager, Biological Methods Development Department

  • Jan 2001 - Dec 2003

  Israel Led multidisciplinary research teams in the development of biological methods supporting pharmaceutical products development.



XTL Biopharmaceuticals Ltd.

• Israel
• Pharmaceutical Manufacturing

• Senior Project Manager

  • Jan 1996 - Jan 2001

  Israel